Novel Therapy of PAD by Combined Transplantation of BMCs
Phase 1
- Conditions
- Peripheral Arterial Disease
- Registration Number
- NCT00411840
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Brief Summary
We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.
After 2 and 13 months walking distance and perfusion indices were monitored.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- severe limb ischemia
Exclusion Criteria
- infectious disease
- cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method ABI, walking distance, capillary-venous oxygen saturation, venous occlusion plethysmography
- Secondary Outcome Measures
Name Time Method feasibility
Trial Locations
- Locations (1)
Heinrich-Heine-University
🇩🇪Duesseldorf, Germany